Industry-Academia Collaboration
Microneedles
Adhesive Patches
Research and Development Activities
Industry-Academia Collaboration
Intellectual Property
Manufacturing
Industry-Academia Collaborative Projects
Teaming up to facilitate quicker solutions to social issues
As an expert in transdermal therapeutic systems (TTS), CosMED Pharmaceutical actively involves itself in research and development projects that feature collaboration with other businesses, universities, and medical institutions.
Solutions to social issues can be uncovered sooner by pursuing research and development with a multidisciplinary outlook and combining the technology cultivated by CosMED Pharmaceutical in transdermal therapeutic systems (TTS) with the expertise of other institutions. CosMED Pharmaceutical is committed to taking full advantage of its unique position as a university-launched venture enterprise with manufacturing capabilities to help resolve social issues in the medical domain.
Development of a Next-generation Continuous Glucose Monitoring (CGM) System
Project partner: Kyoto Prefectural University of Medicine
CosMED Pharmaceutical is collaborating with Kyoto Prefectural University of Medicine in developing a next-generation continuous glucose monitoring system that uses a microneedle patch-based sensor to measure glucose levels. This CGM system will reduce physical stress for patients with diabetes and facilitate self-monitoring at low cost, thereby helping to prevent disease progression, facilitating remote medical care, and contributing to phase 4 (2024 to 2029) of the Japanese government’s plan for the rationalization of medical expenses.
This project has also been selected for the Ministry of Economy, Trade and Industry’s (METI’s) 2024 program to support research and development at growing small and medium-sized enterprises (the Go-Tech program).
Pharmaceutical Development Supporting Research into Transdermal Immunotherapy for Chicken Egg Allergy
Project partner: Mie National Hospital Allergy Center
Transdermal immunotherapy induces immunity to an allergen by infusing an adhesive patch with allergens from the allergy-causing food and placing the patch on the skin. CosMED Pharmaceutical is using its unique gelation technology to develop transdermal allergen delivery patches and provide these patches to the Mie National Hospital Allergy Center, which is researching transdermal immunotherapies against chicken egg allergy.
